(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide (SCH-66336): A Very Potent Farnesyl Protein Transferase Inhibitor as a Novel Antitumor Agent
- 30 October 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (24) , 4890-4902
- https://doi.org/10.1021/jm980462b
Abstract
We have previously shown that appropriate modification of the benzocycloheptapyridine tricyclic ring system can provide potent farnesyl protein transferase (FPT) inhibitors with good cellular activity. Our laboratories have also established that incorporation of either pyridinylacetyl N-oxide or 4-N-carboxamidopiperidinylacetyl moieties results in pharmacokinetically stable inhibitors that are orally efficacious in nude mice. We now demonstrate that further elaboration of the tricyclic ring system by introducing a bromine atom at the 7- or the 10-position of the 3-bromo-8-chlorotricyclic ring system provides compounds that have superior potency and selectivity in FPT inhibition. These compounds have good serum levels and half-lives when given orally to rodents and primates. In vitro and in vivo evaluation of a panel of these inhibitors has led to identification of 15 (SCH 66336) as a highly potent (IC50 = 1.9 nM) antitumor agent that is currently undergoing human clinical trials.Keywords
This publication has 16 references indexed in Scilit:
- Synthesis of Isomeric 3-Piperidinyl and 3-Pyrrolidinyl Benzo[5,6]cyclohepta[1,2-b]pyridines: Sulfonamido Derivatives as Inhibitors of Ras PrenylationBioorganic & Medicinal Chemistry, 1998
- Structure−Activity Relationship of 3-Substituted N-(Pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)- piperidine Inhibitors of Farnesyl-Protein Transferase: Design and Synthesis of in Vivo Active Antitumor CompoundsJournal of Medicinal Chemistry, 1997
- C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in MiceJournal of Medicinal Chemistry, 1997
- Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationBioorganic & Medicinal Chemistry, 1997
- Discovery of novel nonpeptide tricyclic inhibitors of ras farnesyl protein transferaseBioorganic & Medicinal Chemistry, 1997
- Development of Highly Potent Inhibitors of Ras Farnesyltransferase Possessing Cellular andin VivoActivityJournal of Medicinal Chemistry, 1996
- Review Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapyExpert Opinion on Therapeutic Patents, 1995
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Ras C-terminal processing enzymes—New drug targets?Cell, 1991
- p21ras is modified by a farnesyl isoprenoid.Proceedings of the National Academy of Sciences, 1989